share_log

Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Market Cap up CN¥481m Last Week, Benefiting Both Individual Investors Who Own 55% as Well as Insiders

Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Market Cap up CN¥481m Last Week, Benefiting Both Individual Investors Who Own 55% as Well as Insiders

天翼医疗科技股份有限公司(SHSE:688277)的市值上涨了48100万人民币上周,这使得持有55%股份的个人投资者和内部人员受益。
Simply Wall St ·  09/27 18:56

Key Insights

主要见解

  • Tinavi Medical TechnologiesLtd's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public
  • 45% of the business is held by the top 25 shareholders
  • 19% of Tinavi Medical TechnologiesLtd is held by insiders
  • Tinavi医疗科技有限公司的重要个人投资者所有权表明关键决策受到股东的影响,这些股东来自更大的公众
  • 前25大股东占45%的业务。
  • Tinavi医疗科技有限公司的19%股权由内部人士持有

Every investor in Tinavi Medical Technologies Co.,Ltd. (SHSE:688277) should be aware of the most powerful shareholder groups. We can see that individual investors own the lion's share in the company with 55% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

每位投资者都应该知道Tinavi医疗科技有限公司(SHSE:688277)最强大的股东群体。我们可以看到个人投资者拥有公司55%的股权。换句话说,该群体在投资公司时将获得最多(或者损失最多)

While individual investors were the group that benefitted the most from last week's CN¥481m market cap gain, insiders too had a 19% share in those profits.

尽管个人投资者是上周获得的48100万人民币市值增长中受益最多的群体,内部人士也在这些利润中持有19%的份额。

In the chart below, we zoom in on the different ownership groups of Tinavi Medical TechnologiesLtd.

在下面的图表中,我们将重点关注Tinavi Medical TechnologiesLtd各个所有制群体。

big
SHSE:688277 Ownership Breakdown September 27th 2024
SHSE:688277所有权拆分 2024年9月27日

What Does The Institutional Ownership Tell Us About Tinavi Medical TechnologiesLtd?

机构投资者持股意味着什么关于Tinavi Medical TechnologiesLtd?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

机构投资者通常将自己的回报与常见的指数回报进行比较。因此,他们通常会考虑购买包括在相关基准指数中的较大公司。

We can see that Tinavi Medical TechnologiesLtd does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Tinavi Medical TechnologiesLtd, (below). Of course, keep in mind that there are other factors to consider, too.

我们可以看到Tinavi Medical TechnologiesLtd确实有机构投资者;他们持有公司股票的相当一部分。 这可能表明公司在投资社区具有一定的信誉度。然而,在依赖于机构投资者所带来的所谓验证时最好保持警惕。他们也有时会犯错。 如果两家大型机构投资者同时尝试出售某只股票,很常见会看到股价大幅下跌。 因此,值得检查Tinavi Medical TechnologiesLtd的过去盈利轨迹(下文)。 当然,也要记住还有其他因素需要考虑。

big
SHSE:688277 Earnings and Revenue Growth September 27th 2024
SHSE:688277在2024年9月27日的收益和营业收入增长

Tinavi Medical TechnologiesLtd is not owned by hedge funds. Songgen Zhang is currently the largest shareholder, with 17% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 7.4% and 5.3%, of the shares outstanding, respectively.

Tinavi医疗技术有限公司并不属于对冲基金所有。目前最大的股东是宋根张,持有流通股的17%。同时,第二和第三大股东分别持有流通股的7.4%和5.3%。

Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

我们的研究表明,前25大股东共控制了公司股份的不到一半,这意味着公司的股份广泛分散,没有主导股东。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known.

尽管研究一家公司的机构所有权可以为您的研究增添价值,但研究分析师建议以深入了解股票的预期表现也是一个好的做法。我们的信息表明,该股票没有任何分析师的覆盖,因此可能为人所知甚少。

Insider Ownership Of Tinavi Medical TechnologiesLtd

Tinavi医疗技术有限公司内部人员持股情况

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

虽然内部人员的精确定义可能具有主观性,但几乎所有人都认为董事会成员是内部人员。管理层最终向董事会负责。然而,如果经理是创始人或CEO,那么他们成为执行董事会成员并不罕见。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多数人认为内部所有权是积极的,因为它可以表示董事会与其他股东的利益相一致。但是,在某些场合下,这个团体的权力过于集中。

It seems insiders own a significant proportion of Tinavi Medical Technologies Co.,Ltd.. It has a market capitalization of just CN¥3.1b, and insiders have CN¥581m worth of shares in their own names. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.

看起来内部持有一家重要比例的Tinavi医疗技术有限公司的股份。其市值仅为31亿人民币,并且内部人士名下拥有5.81亿人民币的股份。这可能表明创始人仍然持有大量股份。您可以点击这里查看是否有买入或卖出。

General Public Ownership

一般大众所有权

The general public, who are usually individual investors, hold a substantial 55% stake in Tinavi Medical TechnologiesLtd, suggesting it is a fairly popular stock. This level of ownership gives investors from the wider public some power to sway key policy decisions such as board composition, executive compensation, and the dividend payout ratio.

普通大众,通常是个人投资者,在Tinavi医疗科技有限公司中持有相当大的55%股份,表明这是一支相当受欢迎的股票。这种所有权水平赋予了更广泛大众的投资者一定的影响力,可以左右关键政策决策,如董事会构成、高管薪酬以及股息支付比率。

Private Equity Ownership

股权投资公司持有8.8%的股份,有能力参与塑造以价值创造为重点的公司策略。一些投资者可能会因此而受到鼓舞,因为股权投资公司有时可以鼓励市场看到公司的价值,从而采取有益的策略。另外,那些持有者可能在将其上市后退出投资。

Private equity firms hold a 11% stake in Tinavi Medical TechnologiesLtd. This suggests they can be influential in key policy decisions. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.

股权投资公司持有Tinavi Medical TechnologiesLtd 11%的股份。 这表明他们可能对重要政策决策具有影响力。 有些人可能会喜欢这一点,因为股权投资者有时是激进主义者,能够追究管理层的责任。 但有时,股权投资是在出售资产,将公司转为上市公司。

Private Company Ownership

私有公司的所有权

We can see that Private Companies own 10%, of the shares on issue. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

我们可以看到私人公司持有已发行股份的10%。私人企业可能是相关方。有时,内部人士通过持有私人企业中的股份,而不是作为个人拥有对公众公司的利益。虽然很难得出任何广泛的结论,但这是一个值得进一步研究的领域。

Next Steps:

下一步:

It's always worth thinking about the different groups who own shares in a company. But to understand Tinavi Medical TechnologiesLtd better, we need to consider many other factors. For instance, we've identified 2 warning signs for Tinavi Medical TechnologiesLtd that you should be aware of.

值得考虑拥有公司股份的不同群体。 但要更好地了解Tinavi Medical TechnologiesLtd,我们需要考虑许多其他因素。 例如,我们已经识别出Tinavi Medical TechnologiesLtd的2个警告信号,您应该注意。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

当然,您可能会在其他地方找到一项出色的投资。因此,请查看此免费的有趣公司列表。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发